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ORIGINAL ARTICLE
Protective effect of artichoke (Cynara scolymus) leaf extract against lead
toxicity in rat
Esfandiar Heidarian1 and Mahmoud Rafieian-Kopaei2
1Clinical Biochemistry Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran and 2Medical Plants Research Center,
Shahrekord University of Medical Sciences, Shahrekord, Iran
Abstract
Context: Artichoke, Cynara scolymus L. (Asteraceae), has many natural antioxidants and multiple
pharmacological actions. Recent studies have shown that it has antitoxic activity.
Objective: Lead (Pb) is a dangerous environmental toxicant that induces a broad range of
dysfunctions in human. This study evaluated the protective effect of the hydroethanolic extract
of artichoke against altered biochemical parameters in rats fed with lead-containing diet.
Materials and methods: Thirty-two rats were randomly divided into four groups. The first
(control) group received standard diet. The second, third and fourth groups received 500mg
lead/kg diet, 500mg lead/kg diet plus 300mg/kg b.w. artichoke extract daily, and 500mg lead/
kg diet plus 1mg vitamin C/100 g b.w. daily for 6 weeks, respectively. Serum lead, lipoprotein
profile, ALT (alanine transaminase), AST (aspartate transaminase), ALP (alkaline phosphatase),
malondialdehyde (MDA) and liver histopathology assessments were conducted.
Results: Serum lead, triglyceride (TG), VLDL, ALT, AST, ALP and MDA levels decreased
significantly (p50.05) in the artichoke-treated group (35.85, 38.26, 38.38, 21.90, 12.81, 26.86 and
46.91%, respectively) compared to lead-intoxicated rats without treatment. No significant
change was observed in serum lead, ALP and ALT between artichoke and vitamin C-treated
groups (p40.05). Furthermore, the liver histopathology in rats treated with artichoke showed a
mild degree of lymphocyte infiltration that was relatively comparable to the control and
vitamin C-treated groups.
Discussion and conclusion: These results clearly show that the artichoke extract in lead-poisoned
rats has suitable chelating properties for the reduction of blood lead levels.
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Introduction
Lead (Pb) and its compounds are known to be major
environmental pollutants adversely affecting human health
(Hernberg, 2000). Lead rapidly accumulates in liver, kidney
and other human organs after intestinal absorption (Mansouri
& Cauli, 2009; Navarro-Moreno et al., 2009). Many previous
studies have suggested that Pb might induce undesirable
complications in laboratory animals and humans, such as
physiological, biochemical, neurological, behavioral and
reproductive dysfunctions (Abdallah et al., 2010; Patrick,
2006). Several mechanisms have been suggested to describe
lead-induced toxicities (Tian & Lawrence, 1995). Oxidative
stress due to Pb toxicity has been considered one of the major
mechanisms of injury in the liver, kidneys, brain and other
organs. Therefore, antioxidants may increase the efficacy of
treatment designed to reduce lead intoxication (Mansouri &
Cauli, 2009). Treatment of Pb toxicity in humans needs to
increase the excretion of Pb from human body by chelation
(Ahamed & Siddiqui, 2007). The current therapeutic drugs,
such as meso-2,3-dimercaptosuccinic acid (DMSA), are
unsuitable for administration in a long period of time (Flora
et al., 2007). Some published studies have shown that some
ethnomedicines have therapeutic effects on Pb toxicity in
animals by improving the histological pictures of organs and
the biochemical parameters towards the normal values (El-
Nekeety et al., 2009; Queiroz et al., 2011; Sharma et al.,
2010). Therefore, the search for natural compounds, with low
or without adverse effects, to reduce Pb toxicity, is warranted.
Artichoke, Cynara scolymus L. (Asteraceae), leaves have
been used in folk medicine for the treatment of diseases such
as hyperlipidemia (Heidarian et al., 2011a; Heidarian &
Soofiniya, 2011; Joy & Haber, 2007). Some researchers have
isolated and identified several bioactive components of
artichoke, i.e., caffeic acid, chlorogenic acid, cynarin and
luteolin. These bioactive components decrease the production
of reactive oxygen species (ROS), lipid peroxidation and the
oxidation of low-density lipoproteins in vitro experiments
(Juzyszyn et al., 2008; Zapolska-Downar et al., 2002). On
the other hand, several studies have reported that vitamin C
has some protective activity against Pb intoxication (Patra
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et al., 2001; Shalan et al., 2005). The treatment of Pb toxicity
with vitamin C is due to its antioxidant efficacy that inhibits
lipid peroxidation enhanced by Pb (Upasani et al., 2001).
Therefore, considering the antioxidant properties of artichoke,
this study was undertaken to evaluate the protective effect of
artichoke extract against Pb toxicity in rat.
Materials and methods
Animals
The study was done on 32 adult male Wistar rats weighing
150–200 g. The animals were acclimated to laboratory
conditions with regular temperature control (23 2 C), a
12:12 h light–dark cycle, and relative humidity of 55 5%.
All animal procedures were performed with regard to Iranian
Animal Ethics Society and local university rules.
Chemicals and reagents
Alanine aminotransferase (ALT), aspartate aminotranferase
(AST) and alkaline phosphatase (ALP) kits were purchased
from Pars Azmon Co. (Tehran, Iran). Lead acetate, 2,4,6-
tripyridyl-s-triazine (TPTZ) were obtained from Sigma (St.
Louis, MO). Vitamin C, 2-thiobarbituric acid (TBA), ferric
chloride (FeCl3  6H2O) and sodium acetate were provided by
Merck Company (Darmstadt, Germany). All other chemicals
used were of analytical grade.
Plant material and extraction preparation
The artichoke was purchased from Isfahan Agricultural
Research Center. The artichoke was air-dried, ground and
extracted two-times with ethanol:water (70:30, v/v) at room
temperature for 2 d. The hydroethanolic extract was filtered
through Whatman No. 1 filter paper. The solvent was then
removed under vacuum and the extract was stored in 5 C
until used. In this study, we used a single dose of the artichoke
extract (300 mg/kg b.w.) based on a previously published
study (Heidarian & Soofiniya, 2011).
Determination of the total phenol, flavonoid and
antioxidant capacity
The total flavonoids content in the artichoke extract was
measured as described by Chang et al. (2002). Total
flavonoids were expressed in terms of rutin equivalents (in
mg/g). Total phenols were determined by the colorimetry
method with the Folin–Ciocalteu reagent (McDonald et al.,
2001). The standard curve was prepared using 12.5, 25, 50,
62.5, 100 and 125 mg/L solutions of gallic acid in methanol
and water (60:40, v/v). Total phenol values were expressed in
terms of gallic acid equivalent (mg/g), as a common reference
compound. The antioxidant activity of the artichoke extract
was determined using a b-carotene-linoleate model system, as
described by Singh et al. (2011).
Experimental design
Animals were randomly divided into four groups (n¼ 8/
group) as follows. The first (control) group received standard
pellet chow (Pars Dam, Tehran, Iran). This group received
0.5 mL distilled water by stomach tube to produce injection
shock similar to other groups. The second group, lead acetate
intoxicated without treatment, received lead acetate (500 mg
lead acetate/kg diet) daily and water ad libitum for 6 weeks
(Shalan et al., 2005). The third group received 500 mg lead
acetate/kg diet and 300 mg/kg b.w. artichoke extract, daily
for 6 weeks by stomach tube. The fourth group, vitamin
C-protected group as a positive herbal antioxidant group
(Acharya et al., 2003; Vij et al., 1998) received 500 mg
lead acetate/kg diet and 1 mg vitamin C/100 g b.w., daily for
6 weeks by stomach tube (Shalan et al., 2005). At the end of
the experimental period, fasted animals were anesthetized
with chloroform and their blood samples were collected in
test tubes. All serum specimens were separated and stored at
80 C until they were analyzed.
Biochemical analysis
Serum total cholesterol (TC), triglycerides (TG), low-density
lipoprotein cholesterol (LDL-C), high-density lipoprotein
cholesterol (HDL-C), ALT, AST and ALP levels were
determined by enzymatic methods (Pars Azmun kit, Tehran,
Iran) using autoanalyzer (BT 3000, Biotecnica Instruments,
SpA Rome, Italy). Pb concentration was determined in serum
by atomic absorption (Varian, model spectr AA 240,
Mulgrave, Australia).
Measurement of serum MDA
Lipid peroxidation in the serum was assessed by measuring
MDA level after reacting MDA with thiobarbituric acid
according to the method of Ohkawa et al. (1979). The serum
samples were mixed with thiobarbituric acid solution and
incubated for 1 h at 95 C with thiobarbituric acid. The
reaction color product was measured spectrophotometrically
at 532 nm using a visible spectrophotometer (Unico, model
1200 UV, Portland, OR). The measurements were done in
duplicates and the results were expressed in mM. MDA
standards were prepared from 1,1,3,3-tetraethoxypropane
(TEP).
Ferric reducing/antioxidant power assay
The ferric reducing/antioxidant power (FRAP) assay of each
sample was measured according to the procedure described by
Benzie and Strain (1996). In this method, the complex
between Fe2þ and TPTZ gives a blue color with absorbance at
593 nm. FeSO4  7H2O was used as a standard of FRAP assay
at a concentration range between 100 to 1000 mM.
Histopathological studies
Immediately after sacrificing rats, the livers were dissected
out and fixed in 10% formalin. After processing (dehydrating
in gradual ethanol (50–100%) and clearing in xylene), the
livers were embedded in paraffin wax and sectioned into 5 mm
thickness using a microtome. The sections were stained with
hematoxylin and eosin (H and E) (Drury & Wallington, 1980)
for photomicroscopic observation, including inflammatory
activity and stage of fibrosis.
Statistical analysis
The results were expressed as meanS.D. All statistical
analyses were performed using SPSS 17.0 statistical software
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(Chicago, IL). Comparison of means was carried out using
One-way Analysis of Variance (ANOVA) and Tukey’s tests.
p Values less than 0.05 were taken as statistically significant.
Results
Total phenol, flavonoid components and antioxidant
capacity of the artichoke extract
The total phenolic content of the artichoke extract was
113.58 9.18 mg of gallic acid equivalent/g dried extract.
The total flavonoid content of the artichoke extract was
39.04 2.31 mg of rutin equivalent/g dried extract. The
antioxidant activity of the artichoke extract was
51.40 5.37% inhibition of b-carotene.
Biochemical results
Table 1 shows the effects of artichoke extract and vitamin C
on some lead sensitive biochemical variables, as well as liver
function related enzymes activities in serum of lead exposed
rats. Administration of lead resulted in a significant increase
(p50.001) in serum ALP, ALT and AST activities of the
second group (lead exposed group without treatment)
compared to the control group (Table 1). In group three
(lead exposed group treated with artichoke extract) the serum
ALP, ALT and AST activities significantly decreased (26.86,
21.90 and 12.81%, respectively) (p50.05) compared to the
second group. Also, in group four (lead exposed group treated
with vitamin C) the serum ALP, ALT and AST activities
significantly decreased (13.76, 18.34 and 14.38%, respect-
ively) (p50.05) compared to the second group. No significant
change was observed in ALP and ALT between artichoke-
and vitamin C-treated groups (p40.05). In group four, the
serum AST activity significantly elevated compared to group
three, whereas serum ALP and ALT activities had no
remarkable change (p40.05) in comparison with group three.
Table 2 summarizes the mean levels of TG, TC, HDL-C,
LDL-C and VLDL-C in the serum of lead-exposed rats. The
levels of serum TG and VLDL-C in the second group (lead-
exposed group without treatment) significantly increased
(27.16 and 27.40%, respectively) (p50.05) compared to the
control group. However, LDL-C and TC remarkably
decreased in the second group compared to the control
group. The serum HDL-C between all groups had no
significant change (p40.05). In group three, the serum
level of TG, TC and VLDL-C significantly decreased (38.26,
13.15 and 38.38%, respectively) (p50.001) in comparison
with the second group. In group four (lead exposed group
treated with vitamin C), the serum levels of TG, TC and
VLDL-C were significantly elevated compared to group three
(lead exposed group treated with artichoke extract). In group
four, the serum levels of TG, TC, LDL-C and VLDL-C had
no remarkable change (p40.05) in comparison with the first
group (control group). Also, in the second group, a significant
elevation (p50.05) in serum MDA (48.43%) and a significant
reduction (p50.05) in serum FRAP (37.87%) was observed
after lead intake with respect to the control group (Table 1). In
group three, the consumption of artichoke extract caused a
suitable reduction (p50.05) of serum MDA (46.91%) in
comparison with the second group (lead-exposed group
without treatment). On the other hand, supplementation with
vitamin C (group four) resulted in a significant reduction
(p50.001) of serum MDA (57.30%) in comparison with
group three. In group three, supplementation with the
artichoke extract caused a significant elevation in serum
FRAP compared to group four. No significant change was
observed in the serum level of antioxidant power between the
first and the third groups (p40.05).
Table 1. Lead induced changes in serum ALT, AST, ALP, MAD and FRAP in different animal groups.
Groups ALT (U/l) AST (U/l) ALP (U/l) MAD (mM) FRAP (mM)
1 47.83 7.27 120.33 11.39 314.33 34.59 29.34 2.84 441.01 27.90
2 65.71 4.68* 178.28 9.48* 619.00 76.20* 43.55 3.80* 273.98 19.41*
3 57.28 5.73*# 130.42 7.45# 483.57 40.34*# 23.12 2.87*# 438.68 24.34#
4 53.66 3.20# 152.66 12.67*#y 533.83 48.11*# 9.87 1.54*#y 329.33 21.71*#y
The data are expressed in mean S.D and n¼ 8 in each group. Normal diet (1); lead-intoxicated rats without treatment (2); lead-intoxicated rats
supplemented with artichoke extract (3); lead-intoxicated rats supplemented with vitamin C (4) groups.
*p50.001 compared with the corresponding value for the first group (normal control animals).
#p50.001 compared with the corresponding value for the second group (lead-intoxicated rats without treatment).
yp50.001 compared with the corresponding value for group three.
Table 2. Lead induced changes in serum TC, TG, LDL-C, HDL-C and VLDL-C lipoprotein levels in different animal groups.
Groups TC (mg/dl) TG (mg/dl) HDL-C (mg/dl) LDL-C (mg/dl) VLDL (mg/dl)
1 61.66 4.71 63.50 6.05 52.31 5.32 26.99 1.68 12.70 1.21
2 52.28 3.19* 80.75 8.11* 58.06 5.01 20.04 1.95* 16.18 2.19*
3 45.42 3.86*# 49.85 5.45*# 56.01 3.65 21.17 3.36* 9.97 1.09#
4 63.50 5.82#y 71.90 8.62y 57.86 4.49 25.01 2.54 14.51 2.43y
The data are expressed in mean S.D and n¼ 8 in each group. Normal diet (1); lead-intoxicated rats without treatment (2); lead-intoxicated rats
supplemented with artichoke extract (3); lead-intoxicated rats supplemented with vitamin C (4) groups.
*p50.001 compared with the corresponding value for the first group (normal control animals).
#p50.001 compared with the corresponding value for the second group (lead-intoxicated rats without treatment).
yp50.001 compared with the corresponding value for group three.
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The efficacy of artichoke extract and vitamin C on
serum lead concentration
Figure 1 shows the serum lead level in the experimental
groups. In the second group (lead-intoxicated group without
treatment) administration of lead resulted in a significant
(p50.001) elevation (96.29%) in the serum lead compared
to the first group. In groups three and four consumption of
artichoke extract or vitamin C resulted in a remarkable
reduction (p50.001) of the serum lead in comparison with
the second group (35.84 and 41.50%, respectively). On the
other hand, no significant change was observed in serum lead
between artichoke and vitamin C-treated groups.
Histopathological findings
Histology of the liver sections of control animals (the first
group) showed normal hepatic cells with well-preserved
cytoplasm and prominent nucleus (Figure 2A).
Histopathological findings in rats without treatment showed
a broad infiltration of the lymphocytes accompanied with
necrosis (Figure 2B and C). Also, Figure 2(B) showed a
macrophage-laden with yellowish brown pigment in rats
without treatment. On the other hand, rats treated with the
artichoke extract showed a mild degree of lymphocyte
infiltration (Figure 2D), almost comparable to the control
and rats treated with vitamin C (group four). Also, in rats
treated with vitamin C (group four), a remarkable reduction
of the histological inflammatory exudate was observed
(Figure 2E) compared with rats without treatment (group two).
Discussion
Lead (Pb) is a dangerous heavy metal for human health.
Therefore, the detection and prevention of lead toxicity is a
main object for international public health (Ahamed &
Siddiqui, 2007). There are several effective chelators of
lead such as DMSA for treating lead toxicity. Nevertheless,
these chelating agents have side effects such as hemolytic
anemia (Flora & Pachauri, 2010). Nowadays, using traditional
and complementary medicine is developing for the treatment
of many diseases because herbal drugs have less toxicity and
side effects compared to synthetic drugs (Heidarian et al.,
2011b). Artichoke has long been used effectively for treating
a variety of diseases in the world (Heidarian & Soofiniya,
2011). The studies carried out on artichoke have shown the
presence of natural antioxidant components such as
Figure 2. Photomicrography of rat liver
sections in experimental groups. (A) Normal
control (the first group); (B and C) lead-
exposed rats without treatment (the second
group); (D) lead-exposed rats supplemented
with artichoke extract (group three); (E) lead-
exposed rats supplemented with vitamin C
(group four) (H&E stain). Figure 2B Shows a
macrophage-laden with yellowish brown
pigment in rats without treatment. (C) Shows
infiltrated mononuclear cells (arrow) in rats
without treatment.
Figure 1. Therapeutic efficacy of artichoke extract and vitamin C on
serum lead concentration. The data are expressed in mean S.D and
n¼ 8 in each group. Normal diet (1); lead-intoxicated rats without
treatment (2); lead-intoxicated rats supplemented with artichoke extract
(3); lead-intoxicated rats supplemented with vitamin C (4) groups.
*p50.001 compared with the corresponding value in the first group
(normal control animals). #p50.001 compared with the corresponding
value in the second group (lead-intoxicated without treatment).
DOI: 10.3109/13880209.2013.777931 Protective effect of artichoke on lead toxicity 1107
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caffeoylquinic acid derivatives, luteolin and apigenin (Wang
et al., 2003). Our results showed that the ethanol extract of
artichoke has an inhibitory activity against lead-induced
toxicity. The administration of vitamin C to lead-intoxicated
rats caused a reduction in serum lead concentration. Previous
studies have reported protective effects of vitamin C against
intoxication with lead (Houston & Johnson, 2000; Shalan
et al., 2005). Studies in rats have demonstrated that vitamin C
could reduce the gastrointestinal lead absorption (Morton
et al., 1985) and promotes the renal excretion of lead (Niazi
et al., 1982). In addition, there is evidence that vitamin C in
the duodenum results in the reduction of ferric iron to the
ferrous state, which competes with lead for intestinal
transporter (Morton et al., 1985; Suzuki & Yoshida, 1979).
Nevertheless, Figure 2 shows that artichoke extract has a
remarkable reduction effect on serum lead concentration in
lead-intoxicated rats compared to vitamin C treatment. This
effect of artichoke extract might be depended on its flavon-
oids because, in a study, it was demonstrated that phenolics
and flavonoids compounds are chelating agents which
significantly reduce blood and tissue lead burden
(Skoczynska et al., 1993). It is worth mentioning here that
in our study the used artichoke extract concentration and
duration time of experiment were limited. Therefore, we
suggest that future studies focus on other possible mechan-
isms of the serum lead concentration-lowering action of the
artichoke extract due to the bioactive components of
artichoke, especially, on glutathione S-transferase, catalase,
glutathione peroxidase (GPx) and glucose 6-phosphate
dehydrogenase (G6PD).
In group two, lead administration resulted in liver damage
and increased ALT, AST, ALP and MDA compared to the
control group (Table 1). The same results have been reported
by other investigators in experimental animals (Shalan et al.,
2005). On the other hand, in groups three and four the
administration of the artichoke leaf extract and vitamin C
caused a reduction in the activity of these enzymes that
indicates the protective effects of the artichoke leaf extract
and vitamin C against liver damage. However, it seems that
artichoke leaf extract is more effective compared to vitamin
C. The liver protection power of artichoke leaf extract against
liver lead damage is seen in Figure 2. The artichoke leaf
extract prevented the increase of blood lead level and
decreased hepatocyte proliferation. Therefore, elevated
serum ALT, AST, ALP and MDA were lowered to that of
normal control after supplementation of intoxicated rats with
artichoke leaf extract. The efficiency of artichoke is possibly
due to its antioxidant and flavonoids such as cynarin,
chlorogenic acid and caffeoylquinic acid. These biologically
active compounds might have chelated lead and result in
reduced lead in the serum and liver tissue. There is evidence
that serum MDA levels were strongly associated with lead
concentration in the tissues (Aykin-Burns et al., 2005). Lead
induces oxidative stress in the body by the generation of
reactive oxygen species (ROS) and decreasing the cell
antioxidant defense system. On the other hand, previous
studies showed that flavonoids are scavengers of peroxyl
radicals and inhibit lipid peroxidation (Polovka et al., 2003).
Therefore, the reduction of serum MDA level in group three is
due to the effects of the artichoke extract flavonoids (Table 1).
Nevertheless, in this study, it seems that vitamin C has a
strong potential to reduce serum MDA level compared to
artichoke extract (Table 1). However, the ability of artichoke
extract for increasing serum antioxidant level was greater than
vitamin C through its flavonoids (Table 1). The high potential
of vitamin C to reduce serum MDA level resulted from
inhibition of the lipid peroxidation by very rapid electron
transfer to aqueous ROS (Jones et al., 1995).
In this study, lead consumption in group two (lead exposed
group without treatment) created a significant reduction in the
serum LDL-C and cholesterol compared to the control group,
which is in accordance with findings of other investigators
(Shalan et al., 2005; Skoczynska et al., 1993). On the other
hand, in this study lead increased the serum triglyceride
concentration in parallel with the reduction in serum choles-
terol level. In group three, supplementation with artichoke
extract caused a reduction in the serum TG and VLDL
concentration compared to group two (lead exposed group
without treatment). The reduction in serum TG and VLDL
levels may be caused by chlorogenic acid that is a bioactive
component of artichoke as a lipid-lowering agent (Joy &
Haber, 2007; Wider et al., 2009). However, supplementation
of lead-intoxicated rats with vitamin C showed no significant
changes in serum TG and VLDL levels in comparison with
group two (lead exposed group without treatment). Therefore,
artichoke extract can be more effective compared to vitamin C
for controlling lipid abnormalities and amelioration of lead
toxicity in lead-intoxicated situation.
Conclusion
The chelating effects of oral ascorbic acid and the ethanol
extract of artichoke in lead-poisoned rats showed equivalent
chelating properties. The beneficial effects of artichoke
extract can be due to its ability to complex with lead and
result in a remarkable reduction of blood-lead levels.
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